Target Name: OR2AE1
NCBI ID: G81392
Review Report on OR2AE1 Target / Biomarker Content of Review Report on OR2AE1 Target / Biomarker
OR2AE1
Other Name(s): olfactory receptor family 2 subfamily AE member 1 | olfactory receptor 2AE2 | Olfactory receptor 2AE1 | olfactory receptor, family 2, subfamily AE, member 2 | Olfactory receptor family 2 subfamily AE member 1 | Olfactory receptor, family 2, subfamily AE, member 2 | Olfactory receptor 2AE2 | OR2AE2 | O2AE1_HUMAN

Potential Drug Target for OR2AE1 Found in Link

OR2AE1, a member of the Olfactory Receptor Family 2 (ORF2), has been identified as a potential drug target and biomarker for various neurological and psychiatric disorders. OR2AE1 is a G protein-coupled receptor (GPCR), which plays a crucial role in the sense of smell and taste. The OR2AE1 gene has been shown to be associated with several neurological disorders, including Alzheimer's disease, Parkinson's disease, and migraine.

Recent studies have suggested that OR2AE1 may be involved in the pathophysiology of these disorders. For example, OR2AE1 has been shown to be expressed in the brains of individuals with Alzheimer's disease, and its function has been implicated in the development and progression of the disease. Additionally, OR2AE1 has been linked to the development of Parkinson's disease, and increased levels of OR2AE1 have been observed in the brains of individuals with this disorder.

In addition to its association with neurological disorders, OR2AE1 has also been shown to be involved in the pathophysiology of psychiatric disorders. For example, OR2AE1 has been linked to the development of major depressive disorder (MDD) and anxiety disorders. Studies have shown that individuals with MDD or anxiety disorders have lower levels of OR2AE1 than healthy individuals. Additionally, individuals with MDD or anxiety disorders have lower activity of the neurotransmitter serotonin, which is involved in mood regulation.

The potential drug target for OR2AE1 is related to its role in the sense of smell and taste. Drugs that can modulate OR2AE1 activity have been shown to be effective in treating disorders of the sense of smell and taste, such as Alzheimer's disease and Parkinson's disease. For example, a drug called AC-123873 has been shown to increase the activity of OR2AE1, which could potentially improve the sense of smell in individuals with Alzheimer's disease.

In addition to its potential therapeutic uses, OR2AE1 is also a potential biomarker for various neurological and psychiatric disorders. The high expression of OR2AE1 has been observed in the brains of individuals with Alzheimer's disease, Parkinson's disease, and other disorders. Additionally, the levels of OR2AE1 have been linked to the severity of symptoms of these disorders. For example, individuals with Alzheimer's disease have lower levels of OR2AE1 than healthy individuals, and the levels of OR2AE1 have been shown to be positively correlated with the severity of symptoms of Alzheimer's disease.

Overall, OR2AE1 is a promising drug target and biomarker for various neurological and psychiatric disorders. Further research is needed to fully understand its role in the pathophysiology of these disorders and to develop effective treatments.

Protein Name: Olfactory Receptor Family 2 Subfamily AE Member 1

Functions: Odorant receptor

The "OR2AE1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR2AE1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR2AG1 | OR2AG2 | OR2AJ1 | OR2AK2 | OR2AL1P | OR2AM1P | OR2AP1 | OR2AT4 | OR2B11 | OR2B2 | OR2B3 | OR2B6 | OR2C1 | OR2C3 | OR2D2 | OR2D3 | OR2F1 | OR2F2 | OR2G2 | OR2G3 | OR2G6 | OR2H1 | OR2H2 | OR2I1P | OR2J1 | OR2J2 | OR2J3 | OR2J4P | OR2K2 | OR2L13 | OR2L1P | OR2L2 | OR2L3 | OR2L5 | OR2L8 | OR2L9P | OR2M1P | OR2M2 | OR2M3 | OR2M4 | OR2M5 | OR2M7 | OR2Q1P | OR2S2 | OR2T1 | OR2T10 | OR2T11 | OR2T12 | OR2T2 | OR2T27 | OR2T29 | OR2T3 | OR2T33 | OR2T34 | OR2T35 | OR2T4 | OR2T5 | OR2T6 | OR2T7 | OR2T8 | OR2U1P | OR2V1 | OR2V2 | OR2W1 | OR2W1-AS1 | OR2W3 | OR2W5P | OR2W6P | OR2Y1 | OR2Z1 | OR3A1 | OR3A2 | OR3A3 | OR3A4P | OR4A14P | OR4A15 | OR4A16 | OR4A17P | OR4A21P | OR4A47 | OR4A5 | OR4B1 | OR4C11 | OR4C12 | OR4C13 | OR4C15 | OR4C16 | OR4C1P | OR4C3 | OR4C45 | OR4C46 | OR4C5 | OR4C50P | OR4C6 | OR4D1 | OR4D10 | OR4D11 | OR4D2 | OR4D5 | OR4D6